NM09

N/A

Report date: 2024/08/30 11:36:07

Base Information

Drug NameNM09
Drug Alias NameNM09NM-09
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNumab Therapeutics AgTillotts Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesTillotts Pharma AgNumab Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A